Stránka klinických studií Nct
Clinical Trial Results:
Quetiapin: Zur Sicherheit, Verträglichkeit und zum Einfluss auf kognitive Funktionen bei Patienten/innen mit einer schizophrenen Psychose Quetiapine: safety and influence on cognitive functions in patients with schizophrenia: a single-trial event-related potential analysis
| Summary | |
EudraCT number | 2004-005078-22 |
Trial protocol | DE |
Global completion date | |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | |
| Results information | |
Results version number | v1(current) |
This version publication date | 05 May 2023 |
First version publication date | 05 May 2023 |
Other versions | |
Summary report(s) | Statement |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.